Benchmark Reiterates Speculative Buy Rating on Intensity Therapeutics, Inc. (INTS)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: INTS) | Delayed: 3.25 +0.06 (1.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.19 | 52 Week High | $ | |||
| Open | $3.14 | 52 Week Low | $ | |||
| Day High | $3.31 | P/E | N/A | |||
| Day Low | $3.14 | EPS | $ | |||
| Volume | 6,412 | |||||
